FDA releases annual summary report on antimicrobials sold or distributed in 2016 for use in food-producing animals.
The U.S. Food & Drug Administration has published its annual report summarizing sales and distribution data for all antimicrobial drugs approved for use in food-producing animals in 2016.
According to FDA, the latest report shows that antimicrobial sales
decreased from 2015 to 2016, with domestic sales and distribution of all
antimicrobials decreasing by 10% and domestic sales and distribution of
medically important antimicrobials decreasing by 14%. In previous years
(between 2009 and 2015), overall sales volumes increased annually, FDA
said.
In its announcement, FDA emphasized that the 2016 summary report does
not reflect changes made under its "Guidance for Industry (GFI) #213,"
which transitioned medically important antimicrobials used in the feed
or water of food-producing animals to Veterinary Feed Directive
marketing status (feed uses) or prescription (water-based uses) and
withdrew growth promotion and feed efficiency indications of affected
products.
The latest summary report captures data for the 2016 calendar year
(January to December 2016), which FDA noted does not account for changes
in sales or distribution resulting from implementation of GFI #213 on
Jan. 1, 2017.
Furthermore, FDA emphasized that sales and distribution data do not
represent the actual use of the products. It is important to acknowledge
that these data are sponsor estimates of product sales and are not
intended to be a substitute for actual usage data, FDA said. For
example, veterinarians and animal producers may purchase drugs but never
actually administer them to animals, or they may administer the drugs
in later years.
Additionally, the agency said species-specific sales estimates should
not be directly compared, because a variety of factors confound direct
comparison of species-specific sales estimates, including differences in
the animal population size, weight, life span and drug metabolism.
In response to the FDA report, the Animal Health Institute (AHI)
said, "Antibiotic sales — whether they go up or down — are not
predictors of public health impact. While today’s sales report is an
interesting piece of the story, we are more encouraged by the recent
data from the National Antimicrobial Resistance Monitoring System that
shows that, for those pathogens that might transfer from animals to
humans, resistance rates in people have been stable or declining. Over
the 20-year life of the program, salmonella resistance in humans has
steadily declined. This trend of reduced resistance began long before
implementation of FDA’s judicious use program and is evidence that
producer supported antimicrobial responsible use programs have been
working."
FDA has published annual summary reports since 2009, in compliance with requirements established by Section 105 of the Animal Drug User Fee Amendments of 2008.
In May 2016, the agency issued a final rule
revising its annual reporting requirements for drug sponsors of
antimicrobials sold or distributed for use in food-producing animals to
obtain estimates of sales broken out by major food-producing species:
cattle, swine, chickens and turkeys. FDA noted that the "2016 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals"
is the first annual summary report to include these species estimates.
FDA anticipates that having these additional species-specific data will
improve the agency’s understanding of sales and distribution data.
Sales data provide insight regarding antimicrobial drugs entering the
marketplace, but additional sources of information should be considered
when assessing progress of efforts to foster judicious antimicrobial
use, including actual usage data, animal demographics, animal health
data and data on resistance, FDA added.
AHI said, "Public policy that focuses only on reducing the amount of
antibiotic used has not reduced antibiotic resistance rates in humans
and can result in more animal disease and death. We will continue to
work with customers, veterinarians and other stakeholders to preserve a
safe food supply and protect public health through the careful and
judicious use of antibiotics to keep food animals healthy."
No comments:
Post a Comment